✦ LIBER ✦

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

✍ Scribed by Robert P. Whitehead; Jacqueline K. Benedetti; James L. Abbruzzese; Bach Ardalan; Stephen Williamson; Ellen R. Gaynor; Stanley P. Balcerzak; John S. Macdonald

Book ID: 111579928
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 70 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000036689.28596.c6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of high-dose 24 hour co

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

✍ Robert P. Whitehead; Jacqueline K. Benedetti; James L. Abbruzzese; Bach Ardalan; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 71 KB

A phase II study of alternating cycles o

A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)

✍ G. Rosati; D. Bilancia; S. De Santis; A. Dinota; A. Rossi; L. Manzione 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A Phase II Study of Oxaliplatin, 5-Fluor

A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer

✍ Sam J. Lubner; Noelle K. LoConte; Kyle D. Holen; William Schelman; James P. Thom 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB

Evaluation of low dose continuous infusi

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology